X-linked adrenoleukodystrophy as an etiological cause of progressive spastic paraplegia: A case report.

Spinal Cord Stimulation for Chronic Neuropathic Pain in Adrenomyeloneuropathy: A Case Report.

Adrenoleukodystrophy in adults: phenotypic characterisation and natural history in a large cohort.

Late-Onset X-linked Adrenoleukodystrophy: A Rare Cause of Progressive Spastic Paraparesis.

Living with adrenoleukodystrophy: adult patient and caregiver perspectives.

Adult onset cerebral adrenoleukodystrophy: report of an atypical case.

Nationwide Study of the Epidemiology and Clinical Features of X-Linked Adrenoleukodystrophy in Denmark.

An Automated Analysis Tool for Diffusion Tensor Imaging-Based Quantitative MRI in X-Linked Adrenoleukodystrophy.

Adrenoleukodystrophy: Current understanding of disease mechanisms, diagnosis, and therapeutic advances-a recent review.

Hypogonadism in adult males with adrenoleukodystrophy.

Clinical, biochemical & molecular spectrum of adrenoleukodystrophy: A single centre experience.

Clinical and radiological characteristics of adult-onset X-linked adrenoleukodystrophy: a Chinese cohort study and review of the literature.

Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4.

Peripheral nerve enlargement and hyperechogenicity in patients with X-linked adrenoleukodystrophy using high-resolution ultrasound.

Gene Therapy of Adrenomyeloneuropathy: Challenges, Target Cells, and Prospectives.

Nervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts.

Home-Based Rehabilitation With Frenkel's Exercises for Adrenomyeloneuropathy: A Case Report.

Novel ABCD1 Variants in X-Linked Adrenoleukodystrophy.

In-frame deletion variant of ABCD1 in a sporadic case of adrenoleukodystrophy.

Generation and Characterization of Human iPSC-Derived Astrocytes with Potential for Modeling X-Linked Adrenoleukodystrophy Phenotypes.

Intracisternal AAV9-MAG-hABCD1 Vector Reverses Motor Deficits in Adult Adrenomyeloneuropathy Mice.

An in vitro and in vivo efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPs.

A case of adrenomyeloneuropathy caused by a novel point mutation in the ABCD1 gene and functional verification.

A spectrum of cognitive-behavioral-movement disorders in adrenoleukodystrophy: A case series from a tertiary care centre in the eastern part of India.

Practical Approach to Longitudinal Neurologic Care of Adults With X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy.

Adrenal insufficiency and the use of mineralocorticoid treatment in male patients with adrenoleukodystrophy; a retrospective analysis of an institutional database.

[Adrenal insufficiency as part of X-linked adrenoleukodystrophy].

Burden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study.

Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening.

Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.

International validation of meaningfulness of postural sway and gait to assess myeloneuropathy in adults with adrenoleukodystrophy.

A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report.

The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology.

Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD).

Intrathecal administration of mesenchymal stem cells in patients with adrenomyeloneuropathy.

Novel ABCD1 variant causes phenotype of adrenomyeloneuropathy with cerebral involvement in Ukrainian siblings: first adult hematopoietic stem cell transplantation for ALD in Ukraine: a case report.

Adrenomyeloneuropathy manifesting as adrenal insufficiency and bilateral lower extremity spastic paraplegia: A case report and literature review.

Considering the myelin-centric hypothesis: insights from Budka's historical adrenomyeloneuropathy case report.

Adrenomyeloneuropathy (AMN): myelinopathy or axonopathy?: Comment on: Considering the myelin-centric hypothesis: insights from Budka's historical adrenomyeloneuropathy case report by E. Salsano and C. Benzoni.

IPSC-Derived Astrocytes to Model Neuroinflammatory and Metabolic Responses in X-linked Adrenoleukodystrophy.

Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans.

X-linked adrenoleukodystrophy and primary adrenal insufficiency.

Molecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy.

A historical look using virtual microscopy: the first case report of adrenomyeloneuropathy (AMN).

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.

Adrenomyeloneuropathy with Later Development of Cerebral Form Caused by a Hemizygous Splice-site Variant in ABCD1.

Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: A case series.

Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy.

Severe Pressure Ulcers in Two Patients With Adrenoleukodystrophy.

Two Single Nucleotide Deletions in the ABCD1 Gene Causing Distinct Phenotypes of X-Linked Adrenoleukodystrophy.

Novel mutations in the ABCD1 gene caused adrenomyeloneuropathy in the Chinese population.

Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.

Neurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening.

MicroRNA and metabolomics signatures for adrenomyeloneuropathy disease severity.

Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.

Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.

Spectrum of Clinical and Imaging Characteristics of 48 X-Linked Adrenoleukodystrophy Patients: Our Experience from a University Hospital.

High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.

ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.

Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia.

Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.

Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.

Identification of Two Novel Mutations of ABCD1 Gene in Pedigrees with X-Linked Adrenoleukodystrophy and Review of the Literature.

Restless Legs Syndrome in X-linked adrenoleukodystrophy.

Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy.

Functional electrical stimulation to aid walking in patients with adrenomyeloneuropathy: A case study and observational series.

Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort.

Traditional Chinese medicine for gait disturbance in adrenoleukodystrophy: A case report and review of literature.

Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression.

Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.

Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.

Diverse clinical manifestations of X-linked adrenoleukodystrophy in a Chinese family with identical multisite variants of ABCD1 gene.

[X-Linked Adrenoleukodystrophy or the Management of Rare Diseases in the General Practice].

Cognitive Functions in Adult-Onset Phenotypes of X-Linked Adrenoleukodystrophy.

The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy.

A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers.

Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.

Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging.

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.

Pain Study in X-Linked Adrenoleukodystrophy in Males and Females.

Multiparametric in vivo analyses of the brain and spine identify structural and metabolic biomarkers in men with adrenomyeloneuropathy.

Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy.

X-linked adrenoleukodystrophy caused by a novel mutation presenting with various phenotypes in a Taiwanese family.

Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy.

A case of female adrenoleukodystrophy carrier with insidious neurogenic bladder.

Optical coherence tomography in adult adrenoleukodystrophy: a cross-sectional and longitudinal study.

High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.

Unusual early-onset and severe adrenomyeloneuropathy in women.

Novel ABCD1 Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease.

Adrenomyeloneuropathy Masquerading as Chronic Myelitis.

Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling.

A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review.

Adrenomyeloneuropathy Presenting with Spastic Gait.

Anesthetic management of pediatric patients diagnosed with X-linked adrenoleukodystrophy: A single-center experience.

Leukoencephalopathy With Predominant Infratentorial Involvement Caused by a Novel ABCD1 Mutation: Does the Spinocerebellar Variant of Adrenoleukodystrophy Exist?

A novel ABCD1 gene mutation causes adrenomyeloneuropathy in a Chinese family.

Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy.

Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.

X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES.

The Effect of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Hereditary Spastic Paraplegia.

Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study.

Longitudinal quantitative magnetic resonance imaging in adrenomyeloneuropathy.

Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases.

Late onset adrenoleukodystrophy: A review related clinical case report.

Targeted gene approach with biochemical assay confirms ABCD1 mutation of X-linked adrenoleukodystrophy in a 62-year-old man with gait imbalance.

Late adult-onset adrenomyeloneuropathy evolving with atypical severe frontal lobe syndrome: Importance of neuroimaging.

Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.

Integrative lipidomic and transcriptomic analysis of X-linked adrenoleukodystrophy reveals distinct lipidome signatures between adrenomyeloneuropathy and childhood cerebral adrenoleukodystrophy.

Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic.

Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy.

Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Novel ABCD1 Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum.

Rare variability in adrenoleukodystrophy: a case report.

A Novel Variant in ABCD1 Gene Presenting as Adolescent-Onset Atypical Adrenomyeloneuropathy With Spastic Ataxia.

Evaluation of afferent pain pathways in adrenomyeloneuropathic patients.

A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment.

Adrenomyeloneuropathy due to mutation in the ABCD1 gene as underlying factor in spastic paraparesis.

Psychiatric disease in an adolescent as a harbinger of cerebral X-linked adrenoleukodystrophy.

Management of X-linked adrenoleukodystrophy in Morocco: actual situation.

Generation of two induced pluripotent stem cell (iPSC) lines from X-linked adrenoleukodystrophy (X-ALD) patients with adrenomyeloneuropathy (AMN).

Microglial dysfunction as a key pathological change in adrenomyeloneuropathy.

Highly asymmetric and subacutely progressive motor weakness with unilateral T2-weighted high intensities along the pyramidal tract in the brainstem in adrenomyeloneuropathy.

X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.

Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy.

Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy.

[Compassionate use of cannabidiol in spray form for the treatment of spastic paraparesis in a patient with adrenomyeloneuropathy].

Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia.

Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy.

A first case of adrenomyeloneuropathy with mutation Y174S of the adrenoleukodystrophy gene.

Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.

Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.

Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.

An ABCD1 Mutation (c.253dupC) Caused Diverse Phenotypes of Adrenoleukodystrophy in an Iranian Consanguineous Pedigree.

CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.

Oligosymptomatic adrenomyeloneuropathy due to a novel mutation in the ABCD1 start codon.

Endocrine Dysfunction in X-Linked Adrenoleukodystrophy.

Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.

The Clinical Features and Diagnosis of Adrenoleukodystrophy: A Case Series of Iranian Family.

Mild phenotype in an adult male with X-linked adrenoleukodystrophy - case report.

Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.

MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.

Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy.

Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.

Chemical Synthesis of a Very Long-Chain Fatty Acid, Hexacosanoic Acid (C26:0), and the Ceramide Containing Hexacosanoic Acid.

A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: A 30-year diagnostic delay caused by misleading biochemical findings.

The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis.

The difficulty in diagnosing X linked adrenoleucodystrophy and the importance of identifying cerebral involvement.

Loss of AMP-activated protein kinase induces mitochondrial dysfunction and proinflammatory response in unstimulated Abcd1-knockout mice mixed glial cells.

Romiplostim mitigates dose-limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy.

Bladder and Bowel Dysfunction Is Common in Both Men and Women with Mutation of the ABCD1 Gene for X-Linked Adrenoleukodystrophy.

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy.